.After antibody-drug conjugate (ADC) specialist Seagen was actually sold to Pfizer in 2014 for a who...
.On the heels of a phase 3 gain that stopped working to make an impression on real estate investors,...
.Don't stop Monte Rosa Rehabs right now. The Boston-based biotech is actually having a ball after si...
.Accept to recently's Chutes & Ladders, our roundup of notable leadership hirings, shootings and ...
.Celebrating his business's upsized initial public offering (IPO), Septerna chief executive officer ...
.AbbVie has come back to the source of its own antipsychotic giant Vraylar seeking an additional run...
.GenSight Biologics is full weeks far from running out of cash. Once more. The biotech merely has en...
.Monopar Rehabs is actually recouping a medicine from the dump of AstraZeneca's unusual ailment pipe...
.Along with brand-new information out on Arcus Biosciences' speculative HIF-2a prevention, one team ...
.After creating a gene therapy relationship with Dyno Rehabs in 2020, Roche is back for additional.I...
.Lundbeck is actually reducing guide market value of its $250 thousand Abide Therapeutics buyout in ...
.The integration of real-world information (RWD) right into procedure expediency as well as web site...
.At this year's Tough Biotech Summit in Boston ma, our team overtook leaders in the biotech sector t...
.Merck & Co. is setting down $30 million beforehand to buy Yale spinout Modifi Biosciences, a dea...
.Alpha-9 Oncology has raised a $175 thousand collection C cycle to stake its clinical-stage radiopha...
.Eye medication creator Ocuphire Pharma is actually getting gene treatment designer Opus Genes in an...
.Roche's severe cough program has faltered to a stop. The drugmaker, which axed the system after the...
.Gilead Sciences and also Merck & Co. have actually directed their once-weekly HIV mixture treatm...
.Lykos Rehabs might possess shed three-quarters of its own team back the FDA's being rejected of its...
.Septerna might be actually yet to reveal "any type of significant scientific records," yet the biot...